See the Difference

Diagnostic imaging and therapeutic agents to help identify and treat disease and improve patient care

Learn More

See the Difference

Improved diagnostic information for better patient management

Learn More

Play Video

See the Difference

Brands you know; Quality you trust; Reliability you demand daily

Learn More

See the Difference

Advancing the art of science and imaging

Learn More

See the Difference

FOURSIGHT – A New Vision for Prostate Imaging

Learn More

News

Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.

Read More

Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent

Read More

PyL™ (18F-DCFPyL), Lantheus’ PSMA-Targeted Prostate Cancer Imaging Agent, to be Used in POINT Biopharma’s PSMA-Targeted Radioligand Therapeutic Phase 3 Trial in Patients with Metastatic Castration Resistant Prostate Cancer

Read More

Coronavirus (COVID-19) Updates

Providing you with important information regarding our response to the C0VID-19 pandemic.
(updated 1/8/2020)

View a Lantheus webinar:
COVID-19: Clinical Experiences from the Front Line in NYC

Read More

News

Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.

Read More

Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent

Read More

PyL™ (18F-DCFPyL), Lantheus’ PSMA-Targeted Prostate Cancer Imaging Agent, to be Used in POINT Biopharma’s PSMA-Targeted Radioligand Therapeutic Phase 3 Trial in Patients with Metastatic Castration Resistant Prostate Cancer

Read More

callout_technicians

About Us

At Lantheus, we develop, manufacture and commercialize essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care.

Learn More

callout_product

Spotlight

Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.

Learn More

 

callout scientist

Pipeline

We are developing next generation imaging agents to enhance the accuracy, reliability and safety of diagnostic imaging.

Learn More

 

callout_product

Spotlight

Setting the standard for diagnostic quality, safety and commitment with the leading echocardiography contrast agent in North America.

Learn More